Report Detail
Global COVID-19 Recombinant Protein Vaccine Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application
- RnM3952358 |
- 20 April, 2020 |
- Global |
- 112 Pages |
- QYResearch |
- Medical Industry
Preparation and immunogenicity and immunoprotection of Hib polysaccharide conjugate vaccine based on pneumococcal surface adhesive (PsaA).Methods PsaA gene recombinant protein (rPsaA) was prepared by genetic engineering, and then conjugated with Hib polysaccharide by amide condensation.The 3-week-old mice were immunized with this vaccine, and mice were inoculated with tetanus toxoid and haemophilus influenzae type B (Hib) polysaccharide conjugate vaccine (hib-tt) as controls and phosphate buffer (PBS) as blank controls.
In 2019, the global COVID-19 Recombinant Protein Vaccine market size was US$ xx million and it is expected to reach US$ xx million by the end of 2023, with a CAGR of xx% between 2020 and 2023.
The research report studies the COVID-19 Recombinant Protein Vaccine market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
Global COVID-19 Recombinant Protein Vaccine market: Drivers and Restraints
This section covers the various factors driving the global COVID-19 Recombinant Protein Vaccine market. To understand the growth of the market it is important to analyze the various drivers present the market. It provides data by value and volume of different regions and their respective manufacturers. This data will elaborate on the market share occupied by them, predict their revenue concerning strategies, and how they will grow in the future. After explaining the drivers, the report further evaluates the new opportunities and current trends in the market.
Market restraints are factors hampering market growth. Studying these factors is equally pivotal as they help a reader need understand the weaknesses of the market.
Global COVID-19 Recombinant Protein Vaccine market: Segment Analysis
The global COVID-19 Recombinant Protein Vaccine market is split into two segments, type, and application. The product type briefs on the various types of products available in the market. The report also provides data for each product type by revenue for the forecast time period. It covers the price of each type of product. The other segment on the report, application, explains the various uses of the product and end-users. In the report, the researchers have also provided revenue according to the consumption of the product.
Global COVID-19 Recombinant Protein Vaccine market: Regional Analysis
The major regions covered in the report are North America, Europe, China, Rest of Asia Pacific, Central & South America, Middle East & Africa, etc. It includes revenue analysis of each region for the year 2015 to 2023.
Global COVID-19 Recombinant Protein Vaccine market: Key Players
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
By the type, the market is primarily split into
Being Developed
Preclinical
Clinical I
Clinical II
By the application, this report covers the following segments
Pharmaceutical And Biotechnology Companies
Hospital
Academic And Research Organizations
Other
Competitive Landscape:
The COVID-19 Recombinant Protein Vaccine key manufacturers in this market include:
GSK
Johnson & Johnson
Sanofi
Novavax
Pukang Biologic Technology
Clover Biopharmaceuticals
Suzhou Yuzhibo Biotechnology
...
Table of Contents
1 Market Overview of COVID-19 Recombinant Protein Vaccine
- 1.1 COVID-19 Recombinant Protein Vaccine Market Overview
- 1.1.1 COVID-19 Recombinant Protein Vaccine Product Scope
- 1.1.2 Market Status and Outlook
- 1.2 Global COVID-19 Recombinant Protein Vaccine Market Size Overview by Region 2015 VS 2020 VS 2023
- 1.3 Global COVID-19 Recombinant Protein Vaccine Market Size by Region (2020-2023)
- 1.4 Global COVID-19 Recombinant Protein Vaccine Historic Market Size by Region (2020-2021)
- 1.5 Global COVID-19 Recombinant Protein Vaccine Market Size Forecast by Region (2020-2023)
- 1.6 Key Regions COVID-19 Recombinant Protein Vaccine Market Size YoY Growth (2020-2023)
- 1.6.1 North America COVID-19 Recombinant Protein Vaccine Market Size YoY Growth (2020-2023)
- 1.6.2 Europe COVID-19 Recombinant Protein Vaccine Market Size YoY Growth (2020-2023)
- 1.6.3 China COVID-19 Recombinant Protein Vaccine Market Size YoY Growth (2020-2023)
- 1.6.4 Rest of Asia Pacific COVID-19 Recombinant Protein Vaccine Market Size YoY Growth (2020-2023)
- 1.6.5 Latin America COVID-19 Recombinant Protein Vaccine Market Size YoY Growth (2020-2023)
- 1.6.6 Middle East & Africa COVID-19 Recombinant Protein Vaccine Market Size YoY Growth (2020-2023)
2 COVID-19 Recombinant Protein Vaccine Market Overview by Type
- 2.1 Global COVID-19 Recombinant Protein Vaccine Market Size by Type: 2015 VS 2020 VS 2023
- 2.2 Global COVID-19 Recombinant Protein Vaccine Historic Market Size by Type (2020-2021)
- 2.3 Global COVID-19 Recombinant Protein Vaccine Forecasted Market Size by Type (2020-2023)
- 2.4 Being Developed
- 2.5 Preclinical
- 2.6 Clinical I
- 2.7 Clinical II
3 COVID-19 Recombinant Protein Vaccine Market Overview by Type
- 3.1 Global COVID-19 Recombinant Protein Vaccine Market Size by Application: 2015 VS 2020 VS 2023
- 3.2 Global COVID-19 Recombinant Protein Vaccine Historic Market Size by Application (2020-2021)
- 3.3 Global COVID-19 Recombinant Protein Vaccine Forecasted Market Size by Application (2020-2023)
- 3.4 Pharmaceutical And Biotechnology Companies
- 3.5 Hospital
- 3.6 Academic And Research Organizations
- 3.7 Other
4 Global COVID-19 Recombinant Protein Vaccine Competition Analysis by Players
- 4.1 Global COVID-19 Recombinant Protein Vaccine Market Size (Million US$) by Players (2020-2021)
- 4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in COVID-19 Recombinant Protein Vaccine as of 2020)
- 4.3 Date of Key Manufacturers Enter into COVID-19 Recombinant Protein Vaccine Market
- 4.4 Global Top Players COVID-19 Recombinant Protein Vaccine Headquarters and Area Served
- 4.5 Key Players COVID-19 Recombinant Protein Vaccine Product Solution and Service
- 4.6 Competitive Status
- 4.6.1 COVID-19 Recombinant Protein Vaccine Market Concentration Rate
- 4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
- 5.1 GSK
- 5.1.1 GSK Profile
- 5.1.2 GSK Main Business and Company’s Total Revenue
- 5.1.3 GSK Products, Services and Solutions
- 5.1.4 GSK Revenue (US$ Million) (2020-2021)
- 5.1.5 GSK Recent Developments
- 5.2 Johnson & Johnson
- 5.2.1 Johnson & Johnson Profile
- 5.2.2 Johnson & Johnson Main Business and Company’s Total Revenue
- 5.2.3 Johnson & Johnson Products, Services and Solutions
- 5.2.4 Johnson & Johnson Revenue (US$ Million) (2020-2021)
- 5.2.5 Johnson & Johnson Recent Developments
- 5.3 Sanofi
- 5.5.1 Sanofi Profile
- 5.3.2 Sanofi Main Business and Company’s Total Revenue
- 5.3.3 Sanofi Products, Services and Solutions
- 5.3.4 Sanofi Revenue (US$ Million) (2020-2021)
- 5.3.5 Novavax Recent Developments
- 5.4 Novavax
- 5.4.1 Novavax Profile
- 5.4.2 Novavax Main Business and Company’s Total Revenue
- 5.4.3 Novavax Products, Services and Solutions
- 5.4.4 Novavax Revenue (US$ Million) (2020-2021)
- 5.4.5 Novavax Recent Developments
- 5.5 Pukang Biologic Technology
- 5.5.1 Pukang Biologic Technology Profile
- 5.5.2 Pukang Biologic Technology Main Business and Company’s Total Revenue
- 5.5.3 Pukang Biologic Technology Products, Services and Solutions
- 5.5.4 Pukang Biologic Technology Revenue (US$ Million) (2020-2021)
- 5.5.5 Pukang Biologic Technology Recent Developments
- 5.6 Clover Biopharmaceuticals
- 5.6.1 Clover Biopharmaceuticals Profile
- 5.6.2 Clover Biopharmaceuticals Main Business and Company’s Total Revenue
- 5.6.3 Clover Biopharmaceuticals Products, Services and Solutions
- 5.6.4 Clover Biopharmaceuticals Revenue (US$ Million) (2020-2021)
- 5.6.5 Clover Biopharmaceuticals Recent Developments
- 5.7 Suzhou Yuzhibo Biotechnology
- 5.7.1 Suzhou Yuzhibo Biotechnology Profile
- 5.7.2 Suzhou Yuzhibo Biotechnology Main Business and Company’s Total Revenue
- 5.7.3 Suzhou Yuzhibo Biotechnology Products, Services and Solutions
- 5.7.4 Suzhou Yuzhibo Biotechnology Revenue (US$ Million) (2020-2021)
- 5.7.5 Suzhou Yuzhibo Biotechnology Recent Developments
...
6 North America COVID-19 Recombinant Protein Vaccine by Players and by Application
- 6.1 North America COVID-19 Recombinant Protein Vaccine Market Size and Market Share by Players (2020-2021)
- 6.2 North America COVID-19 Recombinant Protein Vaccine Market Size by Application (2020-2021)
7 Europe COVID-19 Recombinant Protein Vaccine by Players and by Application
- 7.1 Europe COVID-19 Recombinant Protein Vaccine Market Size and Market Share by Players (2020-2021)
- 7.2 Europe COVID-19 Recombinant Protein Vaccine Market Size by Application (2020-2021)
8 China COVID-19 Recombinant Protein Vaccine by Players and by Application
- 8.1 China COVID-19 Recombinant Protein Vaccine Market Size and Market Share by Players (2020-2021)
- 8.2 China COVID-19 Recombinant Protein Vaccine Market Size by Application (2020-2021)
9 Rest of Asia Pacific COVID-19 Recombinant Protein Vaccine by Players and by Application
- 9.1 Rest of Asia Pacific COVID-19 Recombinant Protein Vaccine Market Size and Market Share by Players (2020-2021)
- 9.2 Rest of Asia Pacific COVID-19 Recombinant Protein Vaccine Market Size by Application (2020-2021)
10 Latin America COVID-19 Recombinant Protein Vaccine by Players and by Application
- 10.1 Latin America COVID-19 Recombinant Protein Vaccine Market Size and Market Share by Players (2020-2021)
- 10.2 Latin America COVID-19 Recombinant Protein Vaccine Market Size by Application (2020-2021)
11 Middle East & Africa COVID-19 Recombinant Protein Vaccine by Players and by Application
- 11.1 Middle East & Africa COVID-19 Recombinant Protein Vaccine Market Size and Market Share by Players (2020-2021)
- 11.2 Middle East & Africa COVID-19 Recombinant Protein Vaccine Market Size by Application (2020-2021)
12 COVID-19 Recombinant Protein Vaccine Market Dynamics
- 12.1 Industry Trends
- 12.2 Market Drivers
- 12.3 Market Challenges
- 12.4 Porter’s Five Forces Analysis
13 Research Finding /Conclusion
14 Methodology and Data Source
- 14.1 Methodology/Research Approach
- 14.1.1 Research Programs/Design
- 14.1.2 Market Size Estimation
- 14.1.3 Market Breakdown and Data Triangulation
- 14.2 Data Source
- 14.2.1 Secondary Sources
- 14.2.2 Primary Sources
- 14.3 Disclaimer
Summary:
Get latest Market Research Reports on COVID-19 Recombinant Protein Vaccine. Industry analysis & Market Report on COVID-19 Recombinant Protein Vaccine is a syndicated market report, published as Global COVID-19 Recombinant Protein Vaccine Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application. It is complete Research Study and Industry Analysis of COVID-19 Recombinant Protein Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
